Kuvan Union européenne - norvégien - EMA (European Medicines Agency)

kuvan

biomarin international limited - sapropterin dihydrochloride - phenylketonurias - andre alimentary tract and metabolism products, - kuvan er indisert for behandling av hyperfenylalaninemi (hpa) hos voksne og pediatriske pasienter i alle aldre med fenylketonuri (pku) som har vist seg å være responsiv overfor slik behandling. kuvan er også angitt for behandling av hyperphenylalaninaemia (hpa) i voksne og paediatric pasienter i alle aldre med tetrahydrobiopterin (bh4) mangel som har vist seg å være lydhør for slik behandling.

Puri-Nethol 50 mg Norvège - norvégien - Statens legemiddelverk

puri-nethol 50 mg

aspen pharma trading limited - merkaptopurin - tablett - 50 mg

Sapropterin Dipharma Union européenne - norvégien - EMA (European Medicines Agency)

sapropterin dipharma

dipharma arzneimittel gmbh - sapropterin dihydrochloride - phenylketonurias - andre alimentary tract and metabolism products, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

Sapropterin Teva 100 mg Norvège - norvégien - Statens legemiddelverk

sapropterin teva 100 mg

teva gmbh - sapropterindihydroklorid - oppløselig tablett - 100 mg

Artiss Norvège - norvégien - Statens legemiddelverk

artiss

baxter medical ab - fibrinogen, humant / aprotinin / trombin, humant / kalsiumkloriddihydrat - oppløsning til vevslim

Imurel 50 mg Norvège - norvégien - Statens legemiddelverk

imurel 50 mg

aspen pharma trading limited - azatioprin - tablett, filmdrasjert - 50 mg

Imurel 25 mg Norvège - norvégien - Statens legemiddelverk

imurel 25 mg

aspen pharma trading limited - azatioprin - tablett, filmdrasjert - 25 mg

Lariam 250 mg Norvège - norvégien - Statens legemiddelverk

lariam 250 mg

cheplapharm arzneimittel gmbh - meflokinhydroklorid - tablett - 250 mg

Tisseel Norvège - norvégien - Statens legemiddelverk

tisseel

baxter medical ab - fibrinogen, humant / aprotinin / trombin, humant / kalsiumklorid - oppløsning til vevslim - / 3000 kiu/ ml / 500 ie/ ml / 40 mikromol/ ml

Orfadin Union européenne - norvégien - EMA (European Medicines Agency)

orfadin

swedish orphan biovitrum international ab - nitisinone - tyrosinemias - andre alimentary tract and metabolism products, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).